Page 15 - Seth Lederman News Today

Company updates plans for commercial vaccine manufacturing facility in Hamilton Dennis Bragg photo and last updated 2021-06-25 01:55:36-04 HAMILTON — A New Jersey-based pharmaceuticals company says its on track to build a new, commercial scale vaccine manufacturing facility in the Bitterroot Valley. Tonix Pharmaceuticals first announced plans to locate one of its operations on the east side of Hamilton last winter. And this week, company officials are in town for further discussions with ...

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has announced the poster presentation of previously reported results from its ...

Share: Interim Analysis of Second Confirmatory Phase 3 Study in Fibromyalgia  Expected in Third Quarter 2021 Deep Pipeline Progressing with Three Central Nervous System  (CNS) Programs Expected to Enter Phase 2 Trials This Year At March 31, 2021, Cash and Cash Equivalents Totaled Approximately $164 Million CHATHAM, N.J., May 10, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced fina...

GB Sciences Featured & Speaking at the SACHS Associates 4th Annual Neuroscience Innovation Forum LAS VEGAS, NV / ACCESSWIRE / April 27, 2021 / GB Sciences (GBS), Inc. (OTCQB:GBLX), a leading phytomedicine research and biopharmaceutical development company, will be featured during the SPOTLIGHT SHOWCASE at the SACHS Associates 4th Annual Neuroscience Innovation Forum (NIF) for Business Development, Licensing & Investment from April 28 to April 30. The SACHS NIF, which is entirely virtual, will ...

Tonix Pharmaceuticals forms exclusive licensing agreement develop a potential coronavirus treatment Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Dr Seth Lederman tells Proactive the clinical-stage biopharmaceutical company has formed an exclusive licensing agreement develop a potential coronavirus treatment, TNX-3500, from OyaGen, Inc. a pre-clinical biotechnology research company. Dr Lederman says in TNX-3500 is 65 times more potent than Gileads Remdesivir, in-vitro, at inhibiting the cor...

Share this article Share this article PALM BEACH, Fla., April 23, 2021 /PRNewswire/ -- Sleep is an essential need of all species… including homo sapiens, especially now during the pandemic. Sleep disorders are affecting a large pool of population, which has boosted the awareness about these disorders and other related ailments. Increase in the prevalence of sleep disorders has led to an expansion of private care centers and hospitals. These sleep centers have increased awareness among peopl...

(Volker Lannert/University of Bonn) Tonix Pharmaceuticals is opening an early-stage antiviral asset deal with OyaGen as the pair targets COVID-19. The research and license pact, financials of which were not made public, focuses on the antiviral inhibitor of SARS-CoV-2, TNX-3500 (aka sangivamycin, formerly OYA1), which Tonix believes can hit back against the pandemic virus and “potentially other viral disorders.”  The active ingredient of the drug has, in fact, been studied for saf...

Share: NEW YORK, NY / ACCESSWIRE / April 17, 2021 / New To The Street will broadcast Show 168 this Sunday at 10 AM EST on NEWSMAX T.V. The show will feature Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals, a research-driven biotechnology company. Dr. Seth talks about their pipeline of drugs in development - the Rally Study for Fibromyalgia confirmatory phase 3 study, their recent 10K, their recent raise of 110M gross funds raised in 2021, and the TNX 1800 Cov...

(0) NEW YORK, NY / ACCESSWIRE / April 17, 2021 / New To The Street will broadcast Show 168 this Sunday at 10 AM EST on NEWSMAX T.V. The show will feature Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals, a research-driven biotechnology company. Dr. Seth talks about their pipeline of drugs in development - the Rally Study for Fibromyalgia confirmatory phase 3 study, their recent 10K, their recent raise of 110M gross funds raised in 2021, and the TNX 1800 Covid ...

Niche Companies in Tech, Pharma, Cannabis, Solar and more in Attendance